U.S. officials inspected wrong Chinese factory

02/18/2008 | ABC News

The FDA on Monday said that instead of investigating a Chinese manufacturer of an ingredient for Baxter International's blood thinner heparin, it inspected another facility with a similar name. The agency said the incident was an isolated case and that it will visit the Chinese factory this week. Baxter's plant in Cherry Hill, N.J., and another supplier's facility in Waunakee, Wis., are also undergoing inspection.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations